Close menu




 

Fabian Lorenz

  • Small-Caps
  • Micro-Caps

For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.

Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.


Commented by Fabian Lorenz

Commented by Fabian Lorenz on October 12th, 2022 | 11:33 CEST

TUI share soon to be a penny stock? BASF, BioNTech, Cardiol Therapeutics - buy or sell?

  • Biotechnology
  • chemicals

Buy or sell? It is not only the BASF share that is currently the subject of clearly differing opinions. While the gas price brake plans on Monday caused euphoria among investors and correspondingly rising prices for the shares of the chemical company, analysts from Goldman Sachs and Morgan Stanley continue to express pessimism. Experts are similarly cautious about the prospects for TUI. UBS even sees the share of the tourism group on the way to becoming a penny stock. Analysts are more optimistic about BioNTech, but the share is not making any headway at the moment. In contrast, experts see massive upside potential in the biotech gem Cardiol Therapeutics. Cash is now equal to market capitalization, and drug development is making progress.

Read

Commented by Fabian Lorenz on October 6th, 2022 | 13:45 CEST

Buy or sell? Deutsche Bank, BASF, Kleos Space in analyst check

  • Space
  • Technology
  • hightech

Bear market rally, or is the worst over? Either way, equities are trending in a friendly direction this week. This applies to value as well as technology, corporations and small caps. And analysts see further upside potential. Goldmann Sachs, for example, recommends Deutsche Bank shares as one of the sector favorites. But analysts at RBS have a much lower price target. In contrast, analysts see a price potential of over 400% for the space company Kleos Space. The Company is well financed, and in the coming year, sales could increase fivefold. Like investors, BASF's share price opportunities are also hotly debated among experts. The assessments range from sell to buy. The decisive factor for the operating development and the share will be how the gas supply situation will be in winter.

Read

Commented by Fabian Lorenz on October 5th, 2022 | 12:03 CEST

Hydrogen shares step on the gas again: Nel ASA, Plug Power and First Hydrogen profit

  • Hydrogen
  • greenhydrogen
  • Technology

Hydrogen stocks such as Nel, Plug Power and First Hydrogen made significant gains yesterday. Nel is benefiting from a million-dollar grant from the US Department of Defense, and the stock is fighting a downward trend. First Hydrogen, the year's top performer, is also driven by European expansion, its own fueling station network, and a compelling presentation at an investor conference. With the positive industry sentiment, the share prices of Plug Power and ITM Power are also picking up - in some cases, by double digits. Whether as a drive system for vehicles or as a substitute for natural gas, experts believe that hydrogen has a bright future. Governments are promoting it heavily, and companies are also making progress.

Read

Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

  • Technology
  • Biotechnology
  • Investments

The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

Read

Commented by Fabian Lorenz on September 28th, 2022 | 11:22 CEST

Time for bargain hunters? Plug Power, Varta and Pathfinder Ventures

  • Investments
  • Camping
  • RV
  • Electromobility

Growth stocks are currently under particular pressure. But this can also create opportunities for bargain hunters. Perhaps in the case of Varta? The share has crashed sharply after a profit warning. Now, the first analyst has upgraded the share from "sell" to "buy". But even his reasoning does not sound like a new growth story. Plug Power also tends to live on the hope of growth. While the new production facility is technically a milestone, it needs more. In contrast, things are going well at Pathfinder Ventures. The still unknown tourism company is profiting from the camping boom in North America, and its valuation is anything but expensive.

Read

Commented by Fabian Lorenz on September 23rd, 2022 | 11:17 CEST

Nel, Steinhoff, Viva Gold: What is going on?

  • Mining
  • Gold
  • Commodities
  • Investments

Is the rebound coming for the Nel share, or are all the dams breaking? At the moment, this is the situation with the popular hydrogen specialist. After the quarterly figures, Credit Suisse, among others, lowered their thumbs and the share is also clearly battered on the chart. The latter also applies to Viva Gold. Operationally, things are going well for the Canadians. Can a stabilizing gold price turn investors' attention to the low valuation? Investors have been debating for years whether Steinhoff is favorably valued or not. Recently, the share price jumped significantly. What is going on?

Read

Commented by Fabian Lorenz on September 21st, 2022 | 12:33 CEST

BYD, Varta, Globex Mining: Shares with diversification

  • Mining
  • Gold
  • Commodities
  • Electromobility
  • Diversification

Diversification reduces risks. This applies not only to investments but also to companies. BYD, for example, sells not only cars but also batteries, commercial vehicles and more. The focus is currently clearly on the car division, but the Chinese group is also stepping on the gas in its foreign expansion in other areas. With more than 200 holdings in the commodities sector, Globex Mining is also broadly diversified, and its cash holdings alone now account for a good half of its market capitalization. In addition, there is positive news from the projects. Varta is trying to diversify with its entry into battery production. However, the Company is not making any progress in this. Perhaps there will be news at an investor conference next week.

Read

Commented by Fabian Lorenz on September 15th, 2022 | 11:23 CEST

Nordex, Rheinmetall, Barsele Minerals: Turnaround potential!

  • Mining
  • Gold
  • Turnaround
  • Defense

These three stocks have turnaround potential. Admittedly, investing is not easy in the current environment with inflation, rising interest rates and war in Ukraine. But challenging times offer great opportunities. Take Rheinmetall, for example: The stock has corrected by over 30%, yet the prospects are good and analysts also see a price potential of over 70%. Nordex has many problems of its own making, but here too, the industry environment is right, thanks to global investment packages for renewable energy. At Barsele Minerals, the gold price is a burden, but in the meantime, the market capitalization is well below the asset's value, and the recent capital increase was significantly oversubscribed.

Read

Commented by Fabian Lorenz on September 14th, 2022 | 13:05 CEST

Analysts are bullish on BYD, less bullish on Varta and news from Infinity Stone Ventures

  • Mining
  • Commodities
  • Electromobility
  • Lithium

In terms of sales figures, BYD has already overtaken industry star Tesla. But the share could not benefit from this due to the partial sales of major shareholder Berkshire Hathaway. After the price slide, it now seems to be regaining its footing. Analysts are bullish and see great opportunities for the Chinese e-car maker in foreign expansion, among other things. Experts see few opportunities at Varta at the moment, and the chart is battered. Most recently, an analyst reduced the price target to EUR 65. The newsflow currently offers little hope. Infinity Stone Ventures is an entirely different story. The specialist for critical raw materials in Canada benefits from the political environment and is expanding its lithium areas. More news can be expected in the fall.

Read

Commented by Fabian Lorenz on September 9th, 2022 | 10:53 CEST

300% chance with MorphoSys share? News from BioNTech and Defence Therapeutics

  • Biotechnology

Analysts see a 300% price potential for MorphoSys. However, the latest quarterly figures did not give cause for euphoria. And not all analysts are so positive. On the other hand, BioNTech is currently doing well. The Mainz-based Company has received approval for its Omicron vaccine in the UK. However, the sustainable share price is increasingly determined by the pipeline. There is important news concerning the pipeline at Defence Therapeutics. In preclinical studies for the development of a novel cellular vaccine to fight cancer, the survival rate was 100%. The Canadians' unconventional approach could revolutionize modern medicine. More on the three biotech stocks here.

Read